See more here: Coherus BioSciences Appoints Dr. Michael Ryan to its Board of Directors
See more here: Coherus BioSciences Appoints Dr. Michael Ryan to its Board of Directors
See the article here: Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026
View post: ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA® (loncastuximab tesirine-lpyl) and Rituximab in Unfit...
The rest is here: Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
More here: Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires
Here is the original post: Travere Therapeutics to Report Second Quarter 2023 Financial Results
Here is the original post: Cidara Therapeutics Provides Update on Status of Ongoing CD388 Influenza Program
See original here: Cytek Biosciences to Report Second Quarter 2023 Financial Results on August 8, 2023
Read the original post: BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
See the original post: Ceapro Announces Next Phase of Research Collaboration with the Angiogenesis Foundation
Recent Comments